SD Biosensor, Inc.

KOSE:A137310 Stock Report

Market Cap: ₩986.9b

SD Biosensor Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for SD Biosensor.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth45.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article • Nov 03

Does SD Biosensor (KRX:137310) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Aug 20

SD Biosensor's (KRX:137310) Strong Earnings Are Of Good Quality

KOSE:A137310 1 Year Share Price vs Fair Value Explore SD Biosensor's Fair Values from the Community and select yours...
Analysis Article • Jul 02

Here's Why SD Biosensor (KRX:137310) Can Afford Some Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • May 27

There's Reason For Concern Over SD Biosensor, Inc's (KRX:137310) Massive 30% Price Jump

SD Biosensor, Inc ( KRX:137310 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Jan 07

Is SD Biosensor (KRX:137310) Weighed On By Its Debt Load?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Dec 02

Revenues Not Telling The Story For SD Biosensor, Inc (KRX:137310) After Shares Rise 29%

SD Biosensor, Inc ( KRX:137310 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Aug 24

What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You

SD Biosensor, Inc ( KRX:137310 ) shares have had a really impressive month, gaining 25% after a shaky period...
Analysis Article • Aug 08

Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Jul 03

Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price

With a price-to-sales (or "P/S") ratio of 1.7x SD Biosensor, Inc ( KRX:137310 ) may be sending bullish signals at the...
Analysis Article • Feb 28

Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price

You may think that with a price-to-sales (or "P/S") ratio of 2.2x SD Biosensor, Inc ( KRX:137310 ) is a stock worth...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SD Biosensor has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A137310 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2026718,784-470,727315,136370,083N/A
12/31/2025710,581-512,106300,027357,516N/A
9/30/2025696,133113,215234,851295,742N/A
6/30/2025702,551188,000342,226415,702N/A
3/31/2025703,510-105,93656,758128,246N/A
12/31/2024694,574-98,41175,625156,527N/A
9/30/2024674,066-63,21874,305164,325N/A
6/30/2024654,489-192,401-180,043-71,204N/A
3/31/2024649,665-256,179-280,627-158,288N/A
12/31/2023655,677-467,712-386,749-242,319N/A
9/30/2023693,451-693,729-140,61837,220N/A
6/30/20231,093,588-208,280233,279405,806N/A
3/31/20231,725,958214,230464,242707,763N/A
12/31/20222,932,001911,362583,761889,008N/A
9/30/20223,178,3731,344,936488,037773,051N/A
6/30/20223,153,9071,175,426736,3141,002,780N/A
3/31/20223,139,2881,122,436821,6951,101,176N/A
12/31/20212,929,9611,088,4711,042,9121,234,945N/A
9/30/20213,417,1451,294,9301,299,9391,478,430N/A
6/30/20213,426,3501,269,537880,6001,053,264N/A
3/31/20212,755,6201,019,313658,018725,248N/A
12/31/20201,686,163615,636440,232495,382N/A
12/31/201972,9623,153N/A-1,625N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A137310's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A137310's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A137310's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A137310's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A137310's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A137310's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/25 04:39
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SD Biosensor, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jonghyun ParkDAOL Investment & Securities Co., Ltd.
Jaehee WonShinhan Investment Corp.